Heartland Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-704,055
Closed -$9.94M 189
2023
Q3
$9.94M Sell
704,055
-26,634
-4% -$378K 0.56% 75
2023
Q2
$10M Buy
730,689
+790
+0.1% +$11.3K 0.57% 77
2023
Q1
$11.2M Buy
729,899
+16,334
+2% +$250K 0.69% 56
2022
Q4
$9.57M Sell
713,565
-55,696
-7% -$747K 0.61% 72
2022
Q3
$10.2M Sell
769,261
-36,818
-5% -$636K 0.76% 42
2022
Q2
$15.4M Buy
806,079
+28,439
+4% +$539K 1.07% 16
2022
Q1
$15.5M Buy
777,640
+1,306
+0.2% +$26.4K 0.96% 17
2021
Q4
$15.9M Buy
776,334
+13,023
+2% +$278K 0.93% 17
2021
Q3
$16.4M Buy
763,311
+87,138
+13% +$2.1M 0.99% 15
2021
Q2
$19.5M Buy
676,173
+60,242
+10% +$1.63M 1.13% 9
2021
Q1
$15M Buy
615,931
+178,068
+41% +$4.02M 0.95% 19
2020
Q4
$8.5M Buy
437,863
+67,114
+18% +$1.23M 0.61% 60
2020
Q3
$6.45M Buy
370,749
+35,921
+11% +$766K 0.56% 76
2020
Q2
$8.8M Hold
334,828
0.78% 43
2020
Q1
$8.09M Buy
334,828
+103,623
+45% +$2.53M 0.86% 33
2019
Q4
$5.74M Buy
231,205
+124,744
+117% +$2.9M 0.42% 108
2019
Q3
$2.27M Buy
+106,461
New +$2.92M 0.17% 158

Other funds holding PAHC

Heartland Advisors's PAHC Position: Q4 2023 in Review

Heartland Advisors sold out of Phibro Animal Health (PAHC) in Q4 2023, closing a stake of 704,055 shares — an estimated $9.94M sold.

Heartland Advisors first reported a position in PAHC in Q3 2019 and held it in 17 quarters. The position peaked at $19.5M in Q2 2021. 136 funds tracked by Wall St. Rank hold PAHC as of Q4 2023.

  • Heartland Advisors reported no remaining Phibro Animal Health position as of Q4 2023 after selling out during the quarter.
  • Heartland Advisors sold 704,055 Phibro Animal Health shares in Q4 2023, an estimated $9.94M.
  • Heartland Advisors first reported a position in Phibro Animal Health in Q3 2019 and held it in 17 quarters.
  • Heartland Advisors's Phibro Animal Health position peaked at $19.5M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2023.

Based on Heartland Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.